Please use this identifier to cite or link to this item:
Title: Human embryonic stem cells as a cellular model for osteogenesis in implant testing and drug discovery
Keywords: hESCs, Osteogenesis, 3-D printing titanium implant, Purmorphamine, cell model, drug discovery
Issue Date: 5-Jan-2010
Citation: LI MINGMING (2010-01-05). Human embryonic stem cells as a cellular model for osteogenesis in implant testing and drug discovery. ScholarBank@NUS Repository.
Abstract: Human embryonic stem cells (hESCs) hold great promises in many aspects of research and clinical usage. Comparing with other type of stem cells such as adult stem cells and induced pluri-potent stem cells (iPSCs), hESCs are unique with many advantages such as their pluripotency, capable of unlimited self-renewal with intact chromosomal integrity. In daily life, we are subjected to bone injuries and illnesses which our bodies are unable to recover by themselves. The emergence of tissue engineering and cell therapy in the past decades has shown some progress in both research and clinical practice. However, the exploration of hESCs in such applications is still far early from practice. This study aims to open the horizon for the use of hESCs as a cellular model for implant testing and drug discovery along its differentiation process toward osteogenic lineage. Most of the current implant testing relies on adult stem cell (Mesenchymal stem cells, etc.) and primary cells from human tissue.
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
LI MINGMING Thesis for Master of Science O and M surgery FOD.pdf2.05 MBAdobe PDF



Page view(s)

checked on Apr 12, 2019


checked on Apr 12, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.